Jason Cohen, Editor

About the Author Jason Cohen, Editor


H.C. Wainwright Dives In on Amarin Corporation plc (ADR) (AMRN) as REDUCE-IT Topline Data Within Sight

As REDUCE-IT continues to track to expected read-outs in early 2018, H.C. Wainwright analyst Andrew Fein …

Read more

Roth Capital Raises Price Target for Synergy Pharmaceuticals Inc

Late last week, Synergy Pharmaceuticals Inc (NASDAQ:SGYP) announced the FDA approval of its lead drug …

Read more

BTIG Weighs In on Ocular Therapeutix Inc (OCUL) Following NDA Resubmission

This morning, Ocular Therapeutix Inc (NASDAQ:OCUL) announced the resubmission of a New Drug Application (NDA) …

Read more

Oppenheimer Chimes In On Synergy Pharmaceuticals Inc (SGYP) As Trulance Launch Expected In The Coming Weeks

Yesterday after the close, the FDA granted final approval to Synergy Pharmaceuticals Inc’s (NASDAQ:SGYP) Trulance …

Read more

Canaccord Analyst Pounds The Table On Synergy Pharmaceuticals Inc (SGYP)

Canaccord analyst John Newman was out pounding the table on Synergy Pharmaceuticals Inc (NASDAQ:SGYP) Friday, reiterating a …

Read more

Maxim Analyst Chimes In on Anavex Life Sciences Corp. (AVXL)

Anavex Life Sciences Corp. (NASDAQ:AVXL) shares are up 8% in Tuesday’s trading session, after the …

Read more

Maxim Analyst Comments on Cytori Therapeutics Inc Following Azaya Acquisition

Maxim analyst Jason Kolbert reiterated a Buy rating on shares of Cytori Therapeutics Inc (NASDAQ:CYTX) …

Read more

BTIG Positive on Synergy Pharmaceuticals Inc (SGYP) Ahead of Upcoming FDA Decision

Synergy Pharmaceuticals Inc (NASDAQ:SGYP) investors are eagerly awaiting the FDA’s decision on plecanatide’s (for the treatment …

Read more

Healthcare Sell-Side Analysts Head to Sidelines on CoLucid Pharmaceuticals Inc (CLCD) and Alcobra Ltd (ADHD)

CoLucid Pharmaceuticals Inc CoLucid Pharmaceuticals Inc (NASDAQ:CLCD) shares are on the run today after the …

Read more

Biotech Insights: Alcobra Ltd (ADHD), Biogen Inc (BIIB), Juno Therapeutics Inc (JUNO)

Alcobra Ltd  Alcobra Ltd (NASDAQ:ADHD) lost half of its value today after announcing that the …

Read more